PetMed Express Inc (NASDAQ:PETS) — Market Cap & Net Worth
Market Cap & Net Worth: PetMed Express Inc (PETS)
PetMed Express Inc (NASDAQ:PETS) has a market capitalization of $34.62 Million ($34.62 Million) as of September 16, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #23367 globally and #5092 in its home market, demonstrating a -10.50% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying PetMed Express Inc's stock price $1.62 by its total outstanding shares 21371880 (21.37 Million). Also see PetMed Express Inc assets under control for a full breakdown of the balance sheet.
PetMed Express Inc Market Cap History: 2015 to 2026
PetMed Express Inc's market capitalization history from 2015 to 2026. Data shows change from $261.99 Million to $34.62 Million (-16.46% CAGR). Also see PETS cash generation efficiency for how efficiently the company converts equity into cash flow.
Index Memberships
PetMed Express Inc is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Composite
IXIC
|
$41.74 Trillion | 0.00% | #2206 of 3165 |
Weight: PetMed Express Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
PetMed Express Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how PetMed Express Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check PetMed Express Inc share price for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
0.19x
PetMed Express Inc's market cap is 0.19 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $367.03 Million | $234.68 Million | $20.57 Million | 1.56x | 17.85x |
| 2017 | $741.60 Million | $249.18 Million | $23.82 Million | 2.98x | 31.13x |
| 2018 | $390.44 Million | $273.80 Million | $37.28 Million | 1.43x | 10.47x |
| 2019 | $415.91 Million | $283.42 Million | $37.74 Million | 1.47x | 11.02x |
| 2020 | $588.47 Million | $284.12 Million | $25.85 Million | 2.07x | 22.76x |
| 2021 | $481.52 Million | $303.58 Million | $23.92 Million | 1.59x | 20.13x |
| 2022 | $357.14 Million | $273.42 Million | $21.10 Million | 1.31x | 16.93x |
| 2023 | $161.57 Million | $256.58 Million | $5.14 Million | 0.63x | 31.43x |
| 2024 | $103.01 Million | $274.10 Million | -$7.46 Million | 0.38x | N/A |
| 2026 | $34.62 Million | $179.02 Million | -$57.29 Million | 0.19x | N/A |
Competitor Companies of PETS by Market Capitalization
Companies near PetMed Express Inc in the global market cap rankings as of September 16, 2026. Review PetMed Express Inc tangible equity quality to assess the quality of the company's equity after excluding intangible assets.
Key companies related to PetMed Express Inc by market ranking:
- JD HEALTH INTL LTD (F:8ZN): Ranked #1929 globally with a market cap of $12.04 Billion USD ( €10.30 Billion EUR).
- Walgreens Boots Alliance Inc (NASDAQ:WBA): Ranked #2172 globally with a market cap of $10.37 Billion USD.
- ALIB.HL.INF.TEC.UNSP.ADR (F:TWYA): Ranked #2541 globally with a market cap of $8.42 Billion USD ( €7.20 Billion EUR).
- Raia Drogasil S.A (SA:RADL3): Ranked #2963 globally with a market cap of $6.67 Billion USD ( R$34.01 Billion BRL).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #1929 | JD HEALTH INTL LTD | F:8ZN | $12.04 Billion | €3.80 |
| #2172 | Walgreens Boots Alliance Inc | NASDAQ:WBA | $10.37 Billion | $11.98 |
| #2541 | ALIB.HL.INF.TEC.UNSP.ADR | F:TWYA | $8.42 Billion | €8.95 |
| #2963 | Raia Drogasil S.A | SA:RADL3 | $6.67 Billion | R$19.45 |
PetMed Express Inc Historical Marketcap From 2015 to 2026
Between 2015 and today, PetMed Express Inc's market cap moved from $261.99 Million to $ 34.62 Million, with a yearly change of -16.46%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $34.62 Million | -49.38% |
| 2025 | $68.39 Million | -33.61% |
| 2024 | $103.01 Million | -36.24% |
| 2023 | $161.57 Million | -54.76% |
| 2022 | $357.14 Million | -25.83% |
| 2021 | $481.52 Million | -18.17% |
| 2020 | $588.47 Million | +41.49% |
| 2019 | $415.91 Million | +6.52% |
| 2018 | $390.44 Million | -47.35% |
| 2017 | $741.60 Million | +102.05% |
| 2016 | $367.03 Million | +40.09% |
| 2015 | $261.99 Million | -- |
End of Day Market Cap According to Different Sources
On Sep 16th, 2026 the market cap of PetMed Express Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $34.62 Million USD |
| MoneyControl | $34.62 Million USD |
| MarketWatch | $34.62 Million USD |
| marketcap.company | $34.62 Million USD |
| Reuters | $34.62 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About PetMed Express Inc
PetMed Express, Inc., together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional suppleme… Read more